Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction

Recruiting

• Conditions: Coronary Artery Disease; Acute Myocardial Infarction

• Registration Number: NCT06489080
• Lead Sponsor: Peking University First Hospital

Brief Summary

This prospective and prospective cohort study aims to establish a long-term follow-up cohort of patients with acute myocardial infarction, and combine multi-omics studies, wearable devices, artificial intelligence technology, etc., to describe the clinical characteristics of patients with acute myocardial infarction and the changing trend of treatment strategies, and analyze the related influencing factors. Explore new biomarkers and indicators affecting recurrent cardiovascular events for accurate risk stratification and risk prediction; To evaluate the factors affecting lifestyle intervention, drug efficacy and safety, and their impact on outcome, and improve chronic disease management mode, in order to improve the quality of life and prognosis of patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-03-01
• Study First Submitted: 2024-06-23
• Status Verified: 2024-07
• Study First Submitted QC: 2024-07-03
• Last Update Submitted: 2024-07-03
• Study First Posted: 2024-07-05
• Last Update Posted: 2024-07-05
• Primary Completion: 2024-12-31
• Study Completion: 2028-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• Acute myocardial infarction is diagnosed meets the universal definition of acute myocardial infarction

Read More

Exclusion Criteria

• Did not agree to participate in the study

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Major Adverse Cardiovascular Events	5 years	Composite end points of Cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke

Secondary Outcome Measures

Name	Time	Method
Secondary Adverse Cardiovascular Events	5 years	All-cause death, non-cardiac death, myocardial infarction, hospitalization for coronary revascularization, hospitalization for heart failure, hospitalization for acute coronary syndrome, ischemic stroke, hemorrhagic stroke

Trial Locations

Locations (1)

Division of Cardiology, Peking University First Hospital; 🇨🇳 Beijing, Beijing, China